Susceptibility to 5-Aminolevulinic acid based photodynamic therapy in WHO i meningioma cells corresponds to ferrochelatase activity

Photochemistry and Photobiology

Volumn 87, Issue 1, 2011, Pages 235-241

  Hefti, Martin ^a   Holenstein, Fabian ^b   Albert, Ina ^b   Looser, Herbert ^c   Luginbuehl, Vera ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FERROCHELATASE; PHOTOSENSITIZING AGENT;

ARTICLE; ENZYMOLOGY; HUMAN; MENINGIOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AMINOLEVULINIC ACID; CELL LINE, TUMOR; FERROCHELATASE; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; PHOTOSENSITIZING AGENTS;

EID: 78650667235     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2010.00821.x     Document Type: Article

References (32)

1. Dougherty, T. J., (1993) Photodynamic therapy. Photochem. Photobiol. 58, 895-900.
2. Hebeda, K. M., A. E. Saarnak, M. Olivo, H. J. C. M. Sterenborg, and, J. G. Wolber, (1998) 5-aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumors and in the normal brain. Acta Neurochir. 140, 503-513.
3. Eléouet, S., N. Rousset, J. Carré, L. Bourré, V. Vonarx, Y. Lajat, G. M. Beijersbergen van Henegouwen, and, T. Patrice, (2000) In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem. Photobiol. 71, 447-454.
4. Kennedy, J. C., and, R. H. Pottier, (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem 14, 275-292.
5. Tsai, J. C., Y. Y. Hsiao, L. J. Teng, C. T. Chen, and, M. C. Kao, (1999) Comparative study on the ALA photodynamic effects of human glioma and meningioma cells. Lasers Surg. Med. 24 (4), 296-305.
6. Zelenkov, P., R. Baumgartner, K. Bise, M. Heide, R. Meier, S. Stocker, R. Sroka, R. Goldbrunner, and, W. Stummer, (2007) Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model. J. Neurooncol. 82 (1), 49-60.
7. Simpson, D., (1957) The recurrence of intracranial meningiomas after surgical treatment. J. Neurol. Neurosurg. Psychiatr. 20 (1), 22-39.
8. Hashemi, M., U. Schick, W. Hassler, and, M. Hefti, (2010) Tentorial meningiomas with special aspect to the tentorial fold: Management, surgical technique, and outcome. Acta Neurochir (Wien) 152 (5), 827-834.
9. De Vries, J., and, A. K. Wakhloo, (1994) Repeated multifocal recurrence of grade I, grade II, and grade III meningiomas: Regional multicentricity (primary new growth) or metastases? Surg. Neurol. 41, 299-305.
10. Philippon, J., and, P. Cornu, (1991) The recurrence of meningiomas. In Meningiomas (Edited by, O. Al-Mefty,), pp 87-106. Raven Press, New York.
11. Hefti, M., G. von Campe, M. Moschopulos, A. Siegner, H. Looser, and, H. Landolt, (2008) 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: A one-year experience at a single institution. Swiss Med. Wkly. 22, 138 (11-12), 180-185.
12. Morofuji, Y., T. Matsuo, Y. Hayashi, K. Suyama, and, I. Nagata, (2008) Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: Technical case report. Neurosurgery 62 (3 Suppl 1), 102-104.
13. Kajimoto, Y., T. Kuroiwa, S. Miyatake, T. Ichioka, M. Miyashita, H. Tanaka, and, M. Tsuji, (2007) Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report. J. Neurosurg. 10, 1070-1074.
14. Akat, K., H. D. Mennel, P. Kremer, N. Gassler, C. K. E. Bleck, and, J. Kartenbeck, (2003) Molecular characterization of desmosomes in meningiomas and arachnoidal tissue. Acta Neuropathol. 106, 337-347.
15. Püttmann, S., V. Senner, S. Braune, B. Hillmann, R. Exeler, C. H. Rickert, and, W. Paulus, (2005) Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab. Invest. 85 (9), 1163-1171.
16. Lee, H. S., J. B. Lee, S. J. Yun, J. Y. Choi, J. Oh, and, H. R. Park, (2006) Spectrofluorometric determination of PpIX in cells using acridine as internal standard. Bull. Korean Chem. Soc. 27 (7), 1067.
17. Taketani, S., (1999) Measurement of ferrochelatase activity. In Current Protocols in Toxicology (Edited by, M. D. Maines, L. C. Costa, D. J. Reed, S. Sassa, and, J. G. Sipes,), unit 8.7.1-8.7.8. John Wiley & Sons, Inc., New York.
18. Bradford, M. M., (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
19. Ohgari, Y., Y. Nakayasu, S. Kitajima, M. Sawamoto, H. Mori, O. Shimokawa, H. Matsui, and, S. Taketani, (2005) Mechanisms involved in δ- aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: Relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem. Pharmacol. 71 (1-2), 42-49.
20. Campanella, M. E., H. Chu, and, P. S. Low, (2005) Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc. Natl Acad. Sci. USA 102 (7), 2402-2407.
21. Ohgari, Y., Y. Nakayasu, S. Kitajima, M. Sawamoto, H. Mori, O. Shimokawa, H. Matsui, and, S. Taketani, (2005) Mechanisms involved in d-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: Relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem. Pharmacol. 71, 42-49.
22. Brunner, H., F. Hausmann, R. C. Krieg, E. Endlicher, J. Schölmerich, R. Knuechel, and, H. Messmann, (2001) The effects of 5-aminolevulinic acid esters on protoporphyrin IX production in human adenocarcinoma cell lines. Photochem. Photobiol. 74, 721-725.
23. Krieg, R. C., H. Messmann, J. Rauch, S. Seeger, and, R. Knuechel, (2002) Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells. Photochem. Photobiol. 76 (5), 518-525.
24. Lash, A., and, A. Saleem, (1995) Iron metabolism and its regulation. A review. Ann. Clin. Lab. Sci. 25, 20-30.
25. Kauppi, B., B. B. Nielsen, S. Ramaswamy, I. K. Larsen, M. Thelander, L. Thelander, and, H. Eklund, (1996) The three-dimensional structure of mammalian ribonucleotide reductase protein R2 reveals a more-accessible iron-radical site than Escherichia coli R2. J. Mol. Biol. 262, 706-720.
26. Taketani, S., Y. Adachi, and, Y. Nakahashi, (2000) Regulation of the expression of human ferrochelatase by intracellular iron levels. Eur. J. Biochem. 267, 4685-4692.
27. Taketani, S., K. Kakimoto, H. Ueta, R. Masaki, and, T. Furukawa, (2003) Involvement of ABC7 in the biosynthesis of heme in erythroid cells: Interaction of ABC7 with ferrochelatase. Blood 101 (8), 3274-3280.
28. Ferreira, G. C., R. Franco, S. G. Lloyd, I. Moura, J. J. G. Moura, and, B. H. Huynh, (1995) Structure and function of ferrochelatase. J. Bioenerg. Biomembr. 27, 221-229.
29. Ohgari, Y., M. Sawamoto, M. Yamamoto, H. Kohno, and, S. Taketani, (2005) Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer. Hum. Mol. Genet. 14 (2), 327-334.
30. Lilge, L., and, B. C. Wilson, (1998) Photodynamic therapy of intracranial tissues: A preclinical comparative study of four different photosensitizers. J.Clin. Laser Med. Surg. 16, 81-92.
31. Madsen, S. J., C. H. Sun, B. J. Tromberg, A. T. Yeh, R. Sanchez, and, H. Hirschberg, (2002) Effects of combined photodynamic therapy and ionizing radiation on human glioma spheroids. Photochem. Photobiol. 76 (4), 411-416.
32. Pfisterer, W. K., W. P. Hendricks, A. C. Scheck, R. A. Nieman, T. H. Birkner, W. W. Krampla, and, M. C. Preul, (2007) Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: Is it possible to identify a clinically aggressive subset of benign meningiomas? Neurosurgery 61, 1048-1061.